Bahrain Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Favipiravir vs Hydroxychloroquine in COVID -19
Conditions:   SARS-CoV 2;   COVID-19 Interventions:   Drug: Hydroxychloroquine;   Drug: Favipiravir;   Other: Routine care for COVID-19 patients Sponsors:   Royal College of Surgeons in Ireland - Medical University of Bahrain;   Bahrain Defence Force Royal Medical Services, Military Hospital;   Ebrahim Khalil Kanoo Community Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2020 Category: Research Source Type: clinical trials